Srinivasa P. S. Rao

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

Kévin Pethe, Pablo Bifani, Jichan Jang et al. · Nature Medicine · 2013 · 595 citations · Full text

Medicinal Chemistry, Potent Clinical Candidate, Pulmonary Tuberculosis +7

The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating <i>Mycobacterium tuberculosis</i>

Srinivasa P. S. Rao, Sylvie Alonso, Lucinda Rand et al. · Proceedings of the National Academy of Sciences · 2008 · 527 citations · Full text

Bacteriology, Molecular Biology, Chemical Biology +16

Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness

Shilpi Khare, A. S. Nagle, Agnes Biggart et al. · Nature · 2016 · 407 citations · Full text

Proteasome Inhibition, Medicinal Chemistry, Antiparasitic Agent +11

A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy

Kévin Pethe, Patrícia Carvalho de Sequeira, Sanjay Agarwalla et al. · Nature Communications · 2010 · 303 citations · Full text

Bioorganic Chemistry, Tuberculosis Prevention, Bacteriology +24

3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin.

Srinivasa P. S. Rao, Nancy E. Krauss, Julia M. Heerding et al. · Journal of Biological Chemistry · 1994 · 247 citations · Full text

Bioorganic Chemistry, Cytoskeleton, Chemical Biology +17